Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Pharmacy2U scandal prompts BMA call for tougher deterrents

The government should consider custodial sentences as a way to stop businesses following in the footsteps of Pharmacy2U, says the British Medical Association

A GP representative has called for prison sentences for businesses that "abuse" personal data, following the Pharmacy2U data-selling scandal.

The GP arm of the British Medical Association (BMA) said it welcomed a government watchdog investigation into the online pharmacy business, which led to the company being fined £130,000 last week (October 20) for selling 21,500 patient names and addresses to marketing companies in 2014.

But the BMA feels that the “current financial penalties do not offer enough of a deterrent”, Paul Bundy, chair of the organisation’s GP IT committee, said the following day.

“We are pushing for custodial penalties for those who wilfully or recklessly abuse personal data,” Dr Bundy said.

The BMA stressed that it is not responsible for "making this happen” because it is not a regulatory body. But it has "made it clear" to the Information Commissioner's Office [ICO] and the government that "tougher penalties should be considered", it told C+D yesterday (October 26).

Last week, Pharmacy2U managing director Daniel Lee “sincerely apologised” for the “regrettable incident”, which saw patient data sold to an Australian lottery company that the ICO said “deliberately targeted elderly and vulnerable individuals”.

The General Pharmaceutical Council reaffirmed to C+D yesterday (October 26) that it will “study” the ICO’s findings to decide if it should take further action against Pharmacy2U.
 


Are tougher deterrents needed to prevent misuse of patient data?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007787

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel